Anika Therapeutics, Inc. (NASDAQ:ANIK)

CAPS Rating: 3 out of 5

The Company develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair.

Recs

0
Player Avatar geostathis (60.19) Submitted: 2/8/2008 4:36:22 PM : Outperform Start Price: $11.31 ANIK Score: +17.13

Extremely low Enterprise value. Growing and accelerating earnings. Unfairly punished

Report this Post Reply

Featured Broker Partners


Advertisement